J&J | JNJ - Cash And Equivalent

Stock Price
240.43
Daily Change
2.64 1.11%
Monthly
15.88%
Yearly
57.02%
Q1 Forecast
220.25

J&J reported $18.23B in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
AbbVie USD 5.63B 838M Sep/2025
Abbott USD 7.51B 560M Sep/2025
Amgen USD 9.13B 316M Dec/2025
AstraZeneca USD 8.14B 1.08B Sep/2025
Baxter International USD 1.73B 40M Sep/2025
Bayer EUR 5.9B 1.34B Sep/2025
Becton, Dickinson and Co. USD 641M 94M Sep/2025
Biogen USD 3.01B 854.3M Dec/2025
Boston Scientific USD 1.28B 741M Sep/2025
Bristol-Myers Squibb USD 10.21B 5.52B Dec/2025
CONMED USD 38.93M 4.99M Sep/2025
Cooper Companies USD 124.9M 13.3M Jun/2025
Dexcom USD 1.84B 676.7M Sep/2025
Edwards Lifesciences USD 2.69B 587.2M Sep/2025
Eli Lilly USD 9.79B 6.42B Sep/2025
Gilead Sciences USD 5.14B 2.78B Jun/2025
GlaxoSmithKline GBP 3.3B 303M Sep/2025
Globus Medical USD 229.45M 231.82M Jun/2025
Hologic USD 2.17B 208.5M Dec/2025
Insulet USD 757.4M 364.2M Sep/2025
Integra LifeSciences USD 232.19M 14.27M Sep/2025
Intuitive Surgical USD 9.03B 601.6M Dec/2025
J&J USD 18.23B 10.35B Sep/2025
Medtronic USD 1.28B 9M Sep/2025
Merck USD 18.17B 10.16B Sep/2025
Merit Medical Systems USD 392.46M 50.64M Sep/2025
Novartis USD 9.56B 2.9B Sep/2025
Pfizer USD 1.34B 295M Sep/2025
Regeneron Pharmaceuticals USD 18.87B 16.36B Dec/2025
Roche Holding CHF 7.55B 579M Jun/2025
Sanofi EUR 7.66B 1.25B Dec/2025
Stryker USD 3.26B 881M Sep/2025
Tandem Diabetes Care USD 91.95M 27.83M Sep/2025
Teva Pharmaceutical Industries USD 3.56B 1.35B Dec/2025
Vertex Pharmaceuticals USD 6.29B 95.8M Sep/2025
Zimmer Biomet Holdings USD 1.29B 735.8M Sep/2025
Zoetis USD 2.08B 649M Sep/2025